Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the financial results for ....

Date: 23 July 2026 To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex, Bandra (E) Mumbai – 400001 Mumbai – 400051 Security Code: 540596 Security Code: ERIS SUBJECT: BOARD MEETING INTIMATION Dear Sir/Madam, NOTICE IS HEREBY given that a Meeting of the Board of Directors of Eris Lifesciences Limited (“the Company”) is scheduled on Wednesday, July 29, 2026, to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2026. Further, as informed by us vide letter dated June 26, 2026, the trading window has been already closed from July 01, 2026, and will remain closed till 48 hours after the declaration of financial results of the Company pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015, and Policy on ‘Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company’. Thanking You, For Eris Lifesciences Limited Milind Talegaonkar Company Secretary & Compliance Officer ICSI Mem. No: A26493